1[1]Rakieten N, Rakieten ML, Nadkarmi MV. Studies on the diabeteogenic action of streptozotocin[J]. Cancer Chemother Rep,1963; 29(6): 91 - 8
2[2]Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: New Model of Diabetes Mellitus [ J]. Science, 1976; 193(26): 415 - 7
3[3]Rossini AA. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia[J]. Diabetes, 1977; 26(10): 916-20
4[4]Osuna JI, Castro M, Martinez O, MA. Multiple low doses of streptozotocin induced cell mediated immunereaction against βcell in wistar rats[J]. Diabetologia, 1990; 33(8): 721
5[5]Matsuo T, Odaka H. Animal models of diabetes[J]. Metab Dis, 1989;26 (12): 641-8
7[7]Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response[J] .J Clin Invest, 1969; 48( 14): 2129- 39
8[8]Nisimura T. Determination of the effects of a calcium entry blocker no EEG pover spectrum and local cerebral blood flow in streptozotocin-induced hyperglycemic rats with cerebral ischemia: A pharmacological study[J]. J Tokyo Med Coll, 1994;52(8): 569 - 80
9[9]Doi K. Study on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin [ J ]. Folia Endocrinol Jap,1975; 51(12) :129 -47
10[10]Pikin RM and Raynolds WA. Siabetogenic effects of streptozotocin in Rhesus monkeys[J]. Diabetes, 1970; 19: 85- 90
